A retrospective evaluation of the combination of erenumab and onabotulinum toxin A for the prevention of chronic migraine

This publication has 23 references indexed in Scilit:

• The impact of chronic migraine: The Chronic Migraine Epidemiology and Outcomes (CaMEO) Study methods and baseline results
  Cephalalgia, 2014
• Patterns of Use and Reasons for Discontinuation of Prophylactic Medications for Episodic Migraine and Chronic Migraine: Results From the Second International Burden of Migraine Study ( IBMS‐II )
  Headache: The Journal of Head and Face Pain, 2013
• Evidence-based guideline update: Pharmacologic treatment for episodic migraine prevention in adults
  Neurology, 2012
• Randomized, placebo-controlled trial of propranolol added to topiramate in chronic migraine
  Neurology, 2012
• OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial
  Cephalalgia, 2010
• OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial
  Cephalalgia, 2010
• Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers
  Journal of Neurology, Neurosurgery & Psychiatry, 2010
• A Double‐Blind Comparison of OnabotulinumtoxinA (BOTOX^®) and Topiramate (TOPAMAX^®) for the Prophylactic Treatment of Chronic Migraine: A Pilot Study
  Headache: The Journal of Head and Face Pain, 2009
• Chronic migraine in the population
  Neurology, 2008
• Efficacy and Safety of Topiramate for the Treatment of Chronic Migraine: A Randomized, Double‐Blind, Placebo‐Controlled Trial
  Headache: The Journal of Head and Face Pain, 2007